A Prospective, Multicenter, Randomized Controlled Trail Using Drug-coated Balloon to Treat Below The Knee Arterial Stenosis or Occlusion
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Peripheral Artery Disease
- Sponsor
- Zhejiang Zylox Medical Device Co., Ltd.
- Enrollment
- 202
- Locations
- 20
- Primary Endpoint
- Rate of primary patency of the target lesion
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
This is a prospective, multicenter, randomized controlled trail using drug-coated balloon to treat below the knee arterial stenosis or occlusion.
Detailed Description
This trail is conducted in several centers all around China. 202 subjects with below the knee arterial stenosis or occlusion will be recruited and randomized, this trail compares the efficacy and safety of Drug-coated Balloon (Zylox-Tonbridge) with a similar balloon catheter producted by Acotec. The subjects will be followed up when discharged /in 30 days/ 6 months.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 18-85 years;
- •≥70% diameter stenosis or occlusion in the target below-the-knee lesion;
- •Rutherford Category 3-6;
- •Subjects are willing to sign informed consent;
Exclusion Criteria
- •Planned major limb amputation within 30 days after the procedure;
- •In-stent stenosis in the target lesion;
- •Severely calcified target lesions;
- •Creatinine\>2.5mg/dL;
- •History of allergies to anesthetics, contrast agents;
- •Subjects who have participated in any other drug or medical device clinical investigations and haven't reach the primary endpoint;
- •Other circumstances judged by researchers that are not suitable for enrollment.
Outcomes
Primary Outcomes
Rate of primary patency of the target lesion
Time Frame: 180 days
Primary patency is defined as no target lesion occlusion, no clinical symptom driven target lesion revascularization and major limb amputation.
Secondary Outcomes
- Success rate of the technique(Immediately after the intervention)
- Success rate of the operation(Within 7 days)
- Success rate of the device(Intraoperation)